Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Atossa Therapeutics, Inc.

Clinical trials sponsored by Atossa Therapeutics, Inc., explained in plain language.

Atossa Therapeutics, Inc. ATOS NASDAQ

Clinical-stage biopharmaceutical company developing therapies for breast cancer and other conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

Could a daily pill lower breast cancer risk by reducing breast density?

Disease control Completed

This study tested an oral drug called (Z)-endoxifen in 240 premenopausal women with high breast density, a known risk factor for breast cancer. Over six months, researchers measured changes in breast density using mammogram software. The goal was to see if the drug could safely r…

Phase: PHASE2 • Sponsor: Atossa Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC